<SEC-DOCUMENT>0001576885-25-000051-index.html : 20250327
<SEC-HEADER>0001576885-25-000051.hdr.sgml : 20250327
<ACCEPTANCE-DATETIME>20250327163820
ACCESSION NUMBER:		0001576885-25-000051
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
REFERENCES 429:			333-257666
REFERENCES 429:			333-263947
REFERENCES 429:			333-270902
REFERENCES 429:			333-278267
FILED AS OF DATE:		20250327
DATE AS OF CHANGE:		20250327
EFFECTIVENESS DATE:		20250327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acumen Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001576885
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				364108129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286176
		FILM NUMBER:		25780015

	BUSINESS ADDRESS:	
		STREET 1:		427 PARK ST.
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
		BUSINESS PHONE:		925-368-8508

	MAIL ADDRESS:	
		STREET 1:		427 PARK ST.
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>acumenpharma-sx82025.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: acumenpharma-sx82025.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107s-82025.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: exhibit107s-82025.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51s-82025.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: exhibit51s-82025.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>exhibit232eys-8consent.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 4 - file: exhibit232eys-8consent.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: image_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>